{"entity":{"type":"insider","cik":"0001478244","url":"/insider/0001478244","json_url":"/insider/0001478244.json","name":"Currie Mark G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":33,"first":"2011-02-23","last":"2022-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Currie Mark G","source":"filing","n_filings":33,"first_seen":"2011-02-23","last_seen":"2022-08-15"}],"transactions":[{"id":6657626,"accession":"0001209191-22-045808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045808","line_url":"/filing/0001209191-22-045808#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":11.78,"price_display":"11.78","price_state":"stated","total_value":824600.0,"total_display":"824,600.00","total_whole":"824,600","shares_owned_after":521758.0,"shares_owned_after_display":"521,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-15","scope":"insider"},{"id":6251605,"accession":"0001209191-22-035443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-035443","line_url":"/filing/0001209191-22-035443#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190383.0,"shares_display":"190,383","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":2286499.83,"total_display":"2,286,499.83","total_whole":"2,286,500","shares_owned_after":591758.0,"shares_owned_after_display":"591,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-09","scope":"insider"},{"id":4484356,"accession":"0001209191-21-040892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-040892","line_url":"/filing/0001209191-21-040892#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23571.0,"shares_display":"23,571","price_per_share":11.59,"price_display":"11.59","price_state":"stated","total_value":273187.89,"total_display":"273,187.89","total_whole":"273,188","shares_owned_after":570187.0,"shares_owned_after_display":"570,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":2222073,"accession":"0001140361-20-029869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-20-029869","line_url":"/filing/0001140361-20-029869#line-1","is_derivative":false,"issuer_cik":"0001478244","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478244","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (President and CSO)","role_mark":"O","role_mark_label":"Officer (President and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20107.0,"shares_display":"20,107","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":60522.07,"total_display":"60,522.07","total_whole":"60,522","shares_owned_after":251648.0,"shares_owned_after_display":"251,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-30","scope":"insider"},{"id":3253503,"accession":"0001209191-20-004855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-004855","line_url":"/filing/0001209191-20-004855#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":12.59,"price_display":"12.59","price_state":"stated","total_value":755400.0,"total_display":"755,400.00","total_whole":"755,400","shares_owned_after":549272.0,"shares_owned_after_display":"549,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-23","filed_date":"2020-01-24","scope":"insider"},{"id":2820369,"accession":"0001209191-20-004301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-004301","line_url":"/filing/0001209191-20-004301#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8888.0,"shares_display":"8,888","price_per_share":12.8,"price_display":"12.80","price_state":"stated","total_value":113766.4,"total_display":"113,766.40","total_whole":"113,766","shares_owned_after":549272.0,"shares_owned_after_display":"549,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-21","scope":"insider"},{"id":8455765,"accession":"0001209191-19-062322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-062322","line_url":"/filing/0001209191-19-062322#line-2","is_derivative":false,"issuer_cik":"0001478244","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478244","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":62000.0,"total_display":"62,000.00","total_whole":"62,000","shares_owned_after":271755.0,"shares_owned_after_display":"271,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2019-12-31","scope":"insider"},{"id":8455759,"accession":"0001209191-19-062322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-062322","line_url":"/filing/0001209191-19-062322#line-1","is_derivative":false,"issuer_cik":"0001478244","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478244","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":63750.0,"total_display":"63,750.00","total_whole":"63,750","shares_owned_after":296755.0,"shares_owned_after_display":"296,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2019-12-31","scope":"insider"},{"id":8391180,"accession":"0001209191-19-029601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029601","line_url":"/filing/0001209191-19-029601#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":42699.15,"total_display":"42,699.15","total_whole":"42,699","shares_owned_after":528903.0,"shares_owned_after_display":"528,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8024259,"accession":"0001209191-19-023521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-023521","line_url":"/filing/0001209191-19-023521#line-2","is_derivative":false,"issuer_cik":"0001478244","issuer_name":"Cyclerion Therapeutics, Inc.","issuer_ticker":"CYCN","issuer_name_source":null,"issuer_url":"/issuer/0001478244","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":270107.0,"shares_display":"270,107","price_per_share":14.81,"price_display":"14.81","price_state":"stated","total_value":4000284.67,"total_display":"4,000,284.67","total_whole":"4,000,285","shares_owned_after":321755.0,"shares_owned_after_display":"321,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-03","scope":"insider"},{"id":7875902,"accession":"0001209191-19-018232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-018232","line_url":"/filing/0001209191-19-018232#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49500.0,"shares_display":"49,500","price_per_share":13.15,"price_display":"13.15","price_state":"stated","total_value":650925.0,"total_display":"650,925.00","total_whole":"650,925","shares_owned_after":528480.0,"shares_owned_after_display":"528,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-08","filed_date":"2019-03-08","scope":"insider"},{"id":7875899,"accession":"0001209191-19-018232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-018232","line_url":"/filing/0001209191-19-018232#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225500.0,"shares_display":"225,500","price_per_share":13.29,"price_display":"13.29","price_state":"stated","total_value":2996895.0,"total_display":"2,996,895.00","total_whole":"2,996,895","shares_owned_after":577980.0,"shares_owned_after_display":"577,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-08","scope":"insider"},{"id":8189945,"accession":"0001209191-19-012637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-012637","line_url":"/filing/0001209191-19-012637#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13.0,"shares_display":"13","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":186.16,"total_display":"186.16","total_whole":"186","shares_owned_after":803480.0,"shares_owned_after_display":"803,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider"},{"id":8189941,"accession":"0001209191-19-012637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012637","line_url":"/filing/0001209191-19-012637#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1631.0,"shares_display":"1,631","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":23339.61,"total_display":"23,339.61","total_whole":"23,340","shares_owned_after":803493.0,"shares_owned_after_display":"803,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider"},{"id":6426657,"accession":"0001209191-18-054598","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-18-054598","line_url":"/filing/0001209191-18-054598#line-9","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116651.0,"shares_display":"116,651","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":2044892.03,"total_display":"2,044,892.03","total_whole":"2,044,892","shares_owned_after":30124.0,"shares_owned_after_display":"30,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-05","filed_date":"2018-10-09","scope":"insider"},{"id":6426646,"accession":"0001209191-18-054598","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-054598","line_url":"/filing/0001209191-18-054598","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116650.0,"shares_display":"116,650","price_per_share":18.094111787398198,"price_display":"18.09","price_state":"stated","total_value":2110678.14,"total_display":"2,110,678.14","total_whole":"2,110,678","shares_owned_after":52318.0,"shares_owned_after_display":"52,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-04","filed_date":"2018-10-09","scope":"insider","n_lines":2},{"id":6237481,"accession":"0001209191-18-048664","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-048664","line_url":"/filing/0001209191-18-048664#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":18.39,"price_display":"18.39","price_state":"stated","total_value":1195350.0,"total_display":"1,195,350.00","total_whole":"1,195,350","shares_owned_after":775000.0,"shares_owned_after_display":"775,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-24","filed_date":"2018-08-28","scope":"insider"},{"id":6201697,"accession":"0001209191-18-048410","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-048410","line_url":"/filing/0001209191-18-048410#line-8","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":18.39,"price_display":"18.39","price_state":"stated","total_value":1195350.0,"total_display":"1,195,350.00","total_whole":"1,195,350","shares_owned_after":775000.0,"shares_owned_after_display":"775,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-24","scope":"insider"},{"id":6201683,"accession":"0001209191-18-048410","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-048410","line_url":"/filing/0001209191-18-048410#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":18.51,"price_display":"18.51","price_state":"stated","total_value":1203150.0,"total_display":"1,203,150.00","total_whole":"1,203,150","shares_owned_after":775000.0,"shares_owned_after_display":"775,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-22","filed_date":"2018-08-24","scope":"insider"},{"id":6419756,"accession":"0001209191-18-012585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-012585","line_url":"/filing/0001209191-18-012585#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1634.0,"shares_display":"1,634","price_per_share":14.66,"price_display":"14.66","price_state":"stated","total_value":23954.44,"total_display":"23,954.44","total_whole":"23,954","shares_owned_after":18124.0,"shares_owned_after_display":"18,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-22","scope":"insider"},{"id":6392994,"accession":"0001209191-18-005550","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005550","line_url":"/filing/0001209191-18-005550#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":927000.0,"total_display":"927,000.00","total_whole":"927,000","shares_owned_after":775000.0,"shares_owned_after_display":"775,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-26","scope":"insider"},{"id":4903661,"accession":"0001209191-17-021128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-021128","line_url":"/filing/0001209191-17-021128#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":17.06,"price_display":"17.06","price_state":"stated","total_value":1023600.0,"total_display":"1,023,600.00","total_whole":"1,023,600","shares_owned_after":775000.0,"shares_owned_after_display":"775,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-16","scope":"insider"},{"id":4972112,"accession":"0001209191-17-014374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-014374","line_url":"/filing/0001209191-17-014374#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":30492.0,"total_display":"30,492.00","total_whole":"30,492","shares_owned_after":21258.0,"shares_owned_after_display":"21,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-24","scope":"insider"},{"id":2053432,"accession":"0001209191-16-107961","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-107961","line_url":"/filing/0001209191-16-107961#line-3","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":10.86,"price_display":"10.86","price_state":"stated","total_value":1629000.0,"total_display":"1,629,000.00","total_whole":"1,629,000","shares_owned_after":374102.0,"shares_owned_after_display":"374,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-09","filed_date":"2016-03-11","scope":"insider"},{"id":2315795,"accession":"0001209191-16-103048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-103048","line_url":"/filing/0001209191-16-103048","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152154.0,"shares_display":"152,154","price_per_share":8.529575298710517,"price_display":"8.53","price_state":"stated","total_value":1297809.0,"total_display":"1,297,809.00","total_whole":"1,297,809","shares_owned_after":374102.0,"shares_owned_after_display":"374,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider","n_lines":2},{"id":8937504,"accession":"0001209191-15-017252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-017252","line_url":"/filing/0001209191-15-017252#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.67,"price_display":"15.67","price_state":"stated","total_value":391750.0,"total_display":"391,750.00","total_whole":"391,750","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"},{"id":7097281,"accession":"0001209191-14-069252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-069252","line_url":"/filing/0001209191-14-069252#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":13.63,"price_display":"13.63","price_state":"stated","total_value":272600.0,"total_display":"272,600.00","total_whole":"272,600","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-17","scope":"insider"},{"id":6875331,"accession":"0001209191-14-036624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-036624","line_url":"/filing/0001209191-14-036624#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":13.93,"price_display":"13.93","price_state":"stated","total_value":348250.0,"total_display":"348,250.00","total_whole":"348,250","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-23","scope":"insider"},{"id":6353515,"accession":"0001209191-14-029433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-029433","line_url":"/filing/0001209191-14-029433#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":11.67,"price_display":"11.67","price_state":"stated","total_value":291750.0,"total_display":"291,750.00","total_whole":"291,750","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-24","filed_date":"2014-04-28","scope":"insider"},{"id":6837338,"accession":"0001209191-14-012647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-012647","line_url":"/filing/0001209191-14-012647#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":14.43,"price_display":"14.43","price_state":"stated","total_value":216450.0,"total_display":"216,450.00","total_whole":"216,450","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":7011132,"accession":"0001209191-14-004945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-004945","line_url":"/filing/0001209191-14-004945#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.38,"price_display":"14.38","price_state":"stated","total_value":287600.0,"total_display":"287,600.00","total_whole":"287,600","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-23","filed_date":"2014-01-24","scope":"insider"},{"id":9132979,"accession":"0001209191-11-024077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-024077","line_url":"/filing/0001209191-11-024077#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.17,"price_display":"15.17","price_state":"stated","total_value":303400.0,"total_display":"303,400.00","total_whole":"303,400","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-21","filed_date":"2011-04-22","scope":"insider"},{"id":8909933,"accession":"0001209191-11-022978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-022978","line_url":"/filing/0001209191-11-022978#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15137.0,"shares_display":"15,137","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":227055.0,"total_display":"227,055.00","total_whole":"227,055","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-14","filed_date":"2011-04-15","scope":"insider"},{"id":9164616,"accession":"0001209191-11-022795","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-022795","line_url":"/filing/0001209191-11-022795#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24263.0,"shares_display":"24,263","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":363945.0,"total_display":"363,945.00","total_whole":"363,945","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-13","filed_date":"2011-04-13","scope":"insider"},{"id":9164614,"accession":"0001209191-11-022795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-022795","line_url":"/filing/0001209191-11-022795#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-13","scope":"insider"},{"id":9026716,"accession":"0001209191-11-019193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-019193","line_url":"/filing/0001209191-11-019193#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":13.21,"price_display":"13.21","price_state":"stated","total_value":528400.0,"total_display":"528,400.00","total_whole":"528,400","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-21","filed_date":"2011-03-22","scope":"insider"},{"id":8957592,"accession":"0001209191-11-015418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-015418","line_url":"/filing/0001209191-11-015418#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7721.0,"shares_display":"7,721","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":96589.71,"total_display":"96,589.71","total_whole":"96,590","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-03","filed_date":"2011-03-04","scope":"insider"},{"id":8829838,"accession":"0001209191-11-013634","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-013634","line_url":"/filing/0001209191-11-013634#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":23750.0,"total_display":"23,750.00","total_whole":"23,750","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-01","scope":"insider"},{"id":8829835,"accession":"0001209191-11-013634","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-013634","line_url":"/filing/0001209191-11-013634#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379.0,"shares_display":"379","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":4737.5,"total_display":"4,737.50","total_whole":"4,738","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-25","filed_date":"2011-03-01","scope":"insider"},{"id":8927127,"accession":"0001209191-11-012217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-012217","line_url":"/filing/0001209191-11-012217#line-4","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5214.0,"shares_display":"5,214","price_per_share":12.06,"price_display":"12.06","price_state":"stated","total_value":62880.84,"total_display":"62,880.84","total_whole":"62,881","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-23","filed_date":"2011-02-23","scope":"insider"},{"id":8927124,"accession":"0001209191-11-012217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-012217","line_url":"/filing/0001209191-11-012217#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478244","owner_name":"Currie Mark G","owner_display_name":"Currie Mark G","owner_url":"/insider/0001478244","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24786.0,"shares_display":"24,786","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":293714.1,"total_display":"293,714.10","total_whole":"293,714","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-22","filed_date":"2011-02-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Director, Officer (Chief Scientific Officer)","n_filings":30,"first_seen":"2011-02-23","last_seen":"2022-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001755237","name":"Cyclerion Therapeutics, Inc.","url":"/issuer/0001755237","role":"Officer (President and CSO)","n_filings":3,"first_seen":"2019-04-03","last_seen":"2020-12-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478244","retrieved_at":"2026-08-22T13:34:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}